文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

局部剂量分析预测前列腺癌放疗后急性和晚期泌尿毒性:队列与方法效应评估

Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of cohort and method effects.
PubMed 文献 · Radiother Oncol · 2020-03-28

该研究对254例接受IMRT/IGRT(78/80 Gy)的前列腺癌患者进行膀胱剂量表面图(DSM)分析,识别症状相关亚表面(Ssurf)并评估其预测泌尿毒性的能力,同时比较DSM与剂量体积图(DVM)的方法效应及DSM的队列效应。结果显示Ssurf对急性尿潴留、晚期尿潴留和晚期排尿困难的预测AUC分别为0.64、0.68和0.73,Ssurf与Svol模型的预测能力无显著差异,但Ssurf在不同队列间的可重复性较低。

要点

  • DSM可识别膀胱症状相关亚表面,对晚期排尿困难预测AUC达0.73。
  • DSM与DVM识别的亚区域空间一致性相对较好,但DVM识别更多亚区域。
  • Ssurf在不同队列间的可重复性较低,仅晚期排尿困难有共同亚表面。

核心结论

  • DSM与DVM识别的亚区域空间一致性相对较好,但DVM识别更多亚区域。
  • 不同队列间识别的Ssurf可重复性较低。
  • Ssurf与Svol模型的预测能力无显著差异。

研究设计与样本

  • 前瞻性分析254例接受IMRT/IGRT(78/80 Gy)的前列腺癌患者的泌尿毒性。
  • 通过展开膀胱表面生成DSM,进行像素分析识别症状相关Ssurf;同时进行体素DVM分析识别Svol。
  • 采用逻辑回归/Cox回归及ROC曲线下面积(AUC)评估预测能力。

主要发现

  • 识别出三个Ssurf:后部用于急性尿潴留(AUC=0.64),后上部用于晚期尿潴留(AUC=0.68),下前侧部用于晚期排尿困难(AUC=0.73)。
  • 识别出五个Svol:一个位于尿道用于急性尿失禁,四个位于膀胱后部用于急性和晚期尿潴留、晚期排尿困难及血尿。
  • Ssurf与Svol的重叠程度:急性尿潴留中等,晚期尿潴留良好,晚期排尿困难差,AUC范围0.62至0.81。
  • Ssurf和Svol模型的预测能力无显著差异。
  • 在队列间可比较的五种症状中,仅晚期排尿困难发现共同Ssurf,且空间一致性良好。

关键数值与推荐

  • 急性尿潴留Ssurf位于膀胱后部,AUC=0.64。
  • 晚期尿潴留Ssurf位于膀胱后上部,AUC=0.68。
  • 晚期排尿困难Ssurf位于膀胱下前侧部,AUC=0.73。
  • Ssurf与Svol模型AUC范围0.62至0.81,预测能力无显著差异。

临床怎么用

  • DSM分析可用于识别与泌尿毒性相关的膀胱亚区域,辅助放疗计划优化。
  • DSM与DVM预测能力相当,但DVM识别更多亚区域,方法选择需结合临床需求。
  • Ssurf的队列间可重复性较低,跨队列应用需谨慎验证。

局限性

  • Ssurf在不同队列间的可重复性较低,仅晚期排尿困难有共同亚表面。
  • 方法间空间一致性虽相对较好,但DVM识别更多亚区域,可能存在方法效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To perform bladder dose-surface map (DSM) analysis for (1) identifying symptom-related sub-surfaces (Ssurf) and evaluating their prediction capability of urinary toxicity, (2) comparing DSM with dose-volume map (DVM) (method effect), and (3) assessing the reproducibility of DSM (cohort effect). METHODS AND MATERIALS: Urinary toxicities were prospectively analyzed for 254 prostate cancer patients treated with IMRT/IGRT at 78/80 Gy. DSMs were generated by unfolding bladder surfaces in a 2D plane. Pixel-by-pixel analysis was performed to identify symptom-related Ssurf. Likewise, voxel-by-voxel DVM analysis was performed to identify sub-volumes (Svol). The prediction capability of Ssurf and Svol DVHs was assessed by logistic/Cox regression using the area under the ROC curve (AUC). The Ssurf localization and prediction capability were compared to (1) the Svol obtained by DVM analysis in the same cohort and (2) the Ssurf obtained from other DSM studies. RESULTS: Three Ssurf were identified in the bladder: posterior for acute retention (AUC = 0.64), posterior-superior for late retention (AUC = 0.68), and inferior-anterior-lateral for late dysuria (AUC = 0.73). Five Svol were identified: one in the urethra for acute incontinence and four in the posterior bladder part for acute and late retention, late dysuria, and hematuria. The overlap between Ssurf and Svol was moderate for acute retention, good for late retention, and bad for late dysuria, and AUCs ranged from 0.62 to 0.81. The prediction capabilities of Ssurf and Svol models were not significantly different. Among five symptoms comparable between cohorts, common Ssurf was found only for late dysuria, with a good spatial agreement. CONCLUSION: Spatial agreement between methods is relatively good although DVM identified more sub-regions. Reproducibility of identified Ssurf between cohorts is low.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Mylona E, Cicchetti A, Rancati T, et al. Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of cohort and method effects. Radiother Oncol. 2020. PMID: 32224316. doi:10.1016/j.radonc.2020.02.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。